80 related articles for article (PubMed ID: 19886745)
1. 3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease.
di Paola R; Esposito E; Mazzon E; Caminiti R; Toso RD; Pressi G; Cozzocrea S
Free Radic Res; 2010 Jan; 44(1):74-89. PubMed ID: 19886745
[TBL] [Abstract][Full Text] [Related]
2. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J
J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
[TBL] [Abstract][Full Text] [Related]
5. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis.
Mazzon E; Esposito E; Crisafulli C; Riccardi L; Muià C; Di Bella P; Meli R; Cuzzocrea S
J Pineal Res; 2006 Nov; 41(4):363-73. PubMed ID: 17014694
[TBL] [Abstract][Full Text] [Related]
6. Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease.
Mandalari G; Bisignano C; Genovese T; Mazzon E; Wickham MS; Paterniti I; Cuzzocrea S
Int Immunopharmacol; 2011 Aug; 11(8):915-24. PubMed ID: 21354356
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats.
Fitzpatrick LR; Wang J; Le T
J Pharmacol Exp Ther; 2001 Dec; 299(3):915-20. PubMed ID: 11714876
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition reduces acute colonic inflammation in rats.
Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.
Kolgazi M; Jahovic N; Yüksel M; Ercan F; Alican I
J Gastroenterol Hepatol; 2007 Nov; 22(11):1859-65. PubMed ID: 17914960
[TBL] [Abstract][Full Text] [Related]
11. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats.
Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL
Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794
[TBL] [Abstract][Full Text] [Related]
12. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Centorrino T; Terranova ML; Ciccolo A; Britti D; Caputi AP; Thiemermann C
Gut; 2001 Apr; 48(4):478-88. PubMed ID: 11247891
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats.
Mousavizadeh K; Rahimian R; Fakhfouri G; Aslani FS; Ghafourifar P
Eur J Clin Invest; 2009 May; 39(5):375-83. PubMed ID: 19302562
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease.
Meregnani J; Clarençon D; Vivier M; Peinnequin A; Mouret C; Sinniger V; Picq C; Job A; Canini F; Jacquier-Sarlin M; Bonaz B
Auton Neurosci; 2011 Feb; 160(1-2):82-9. PubMed ID: 21071287
[TBL] [Abstract][Full Text] [Related]
16. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.
Esposito E; Mazzon E; Riccardi L; Caminiti R; Meli R; Cuzzocrea S
J Pineal Res; 2008 Sep; 45(2):166-73. PubMed ID: 18429971
[TBL] [Abstract][Full Text] [Related]
18. 5-caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-alpha-induced secretion of interleukin-8 from Caco-2 cells.
Zhao Z; Shin HS; Satsu H; Totsuka M; Shimizu M
J Agric Food Chem; 2008 May; 56(10):3863-8. PubMed ID: 18444659
[TBL] [Abstract][Full Text] [Related]
19. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
20. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
Ursino MG; Vasina V; De Ponti F
Eur J Pharmacol; 2009 Jan; 603(1-3):133-7. PubMed ID: 19103194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]